Global Bioprocessing Development Software 麻豆原创 Research Report 2025

Publication ID:

PB504257777

Publication Date:

May 2, 2025

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

IT Services [2]

Computing & Electronics [3]

Description:

The global market for Bioprocessing Development Software was valued at US$ 877 million in the year 2024 and is projected to reach a revised size of US$ 1141 million by 2031, growing at a CAGR of 4.4% during the forecast period.
Bioprocessing Development Software is a specialized computer program designed to support the development and optimization of biopharmaceutical manufacturing processes. It integrates functionalities such as Design of Experiments (DoE), process modeling, data visualization, and statistical analysis to assist researchers in efficiently designing and refining bioreactions, purification processes, and formulation strategies. Key features include real-time monitoring of critical process parameters (e.g., temperature, pH, dissolved oxygen), predicting process performance, identifying potential risks, and providing data-driven decision-making support. The software is widely used in the development of monoclonal antibodies, vaccines, gene therapies, and other biologics, significantly reducing development timelines and production costs. Advanced versions may also incorporate AI algorithms for more accurate process scale-up and large-scale production.
North American market for Bioprocessing Development Software is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Bioprocessing Development Software is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Bioprocessing Development Software in Biopharmaceuticals is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Bioprocessing Development Software include Merck, Genedata, Invert, Eppendorf, Koerber-Pharma, Vimachem, Alkemy Innovation, Cytiva, IDBS, Infors, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Bioprocessing Development Software, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bioprocessing Development Software.
The Bioprocessing Development Software market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Bioprocessing Development Software market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Bioprocessing Development Software companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
麻豆原创 Segmentation
By Company
Merck
Genedata
Invert
Eppendorf
Koerber-Pharma
Vimachem
Alkemy Innovation
Cytiva
IDBS
Infors
Sapio
Sartorius
Securecell
Synthace
Thermo Fisher Scientific
Segment by Type
Cloud-based
On-premises
Segment by Application
Biopharmaceuticals
Research Institutes
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Bioprocessing Development Software company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global Bioprocessing Development Software 麻豆原创 Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Cloud-based
1.2.3 On-premises
1.3 麻豆原创 by Application
1.3.1 Global Bioprocessing Development Software 麻豆原创 Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Biopharmaceuticals
1.3.3 Research Institutes
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Bioprocessing Development Software 麻豆原创 Perspective (2020-2031)
2.2 Global Bioprocessing Development Software Growth Trends by Region
2.2.1 Global Bioprocessing Development Software 麻豆原创 Size by Region: 2020 VS 2024 VS 2031
2.2.2 Bioprocessing Development Software Historic 麻豆原创 Size by Region (2020-2025)
2.2.3 Bioprocessing Development Software Forecasted 麻豆原创 Size by Region (2026-2031)
2.3 Bioprocessing Development Software 麻豆原创 Dynamics
2.3.1 Bioprocessing Development Software Industry Trends
2.3.2 Bioprocessing Development Software 麻豆原创 Drivers
2.3.3 Bioprocessing Development Software 麻豆原创 Challenges
2.3.4 Bioprocessing Development Software 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Top Bioprocessing Development Software Players by Revenue
3.1.1 Global Top Bioprocessing Development Software Players by Revenue (2020-2025)
3.1.2 Global Bioprocessing Development Software Revenue 麻豆原创 Share by Players (2020-2025)
3.2 Global Top Bioprocessing Development Software Players by Company Type and 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Bioprocessing Development Software Revenue
3.4 Global Bioprocessing Development Software 麻豆原创 Concentration Ratio
3.4.1 Global Bioprocessing Development Software 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Bioprocessing Development Software Revenue in 2024
3.5 Global Key Players of Bioprocessing Development Software Head office and Area Served
3.6 Global Key Players of Bioprocessing Development Software, Product and Application
3.7 Global Key Players of Bioprocessing Development Software, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Bioprocessing Development Software Breakdown Data by Type
4.1 Global Bioprocessing Development Software Historic 麻豆原创 Size by Type (2020-2025)
4.2 Global Bioprocessing Development Software Forecasted 麻豆原创 Size by Type (2026-2031)
5 Bioprocessing Development Software Breakdown Data by Application
5.1 Global Bioprocessing Development Software Historic 麻豆原创 Size by Application (2020-2025)
5.2 Global Bioprocessing Development Software Forecasted 麻豆原创 Size by Application (2026-2031)
6 North America
6.1 North America Bioprocessing Development Software 麻豆原创 Size (2020-2031)
6.2 North America Bioprocessing Development Software 麻豆原创 Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Bioprocessing Development Software 麻豆原创 Size by Country (2020-2025)
6.4 North America Bioprocessing Development Software 麻豆原创 Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Bioprocessing Development Software 麻豆原创 Size (2020-2031)
7.2 Europe Bioprocessing Development Software 麻豆原创 Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Bioprocessing Development Software 麻豆原创 Size by Country (2020-2025)
7.4 Europe Bioprocessing Development Software 麻豆原创 Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Bioprocessing Development Software 麻豆原创 Size (2020-2031)
8.2 Asia-Pacific Bioprocessing Development Software 麻豆原创 Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Bioprocessing Development Software 麻豆原创 Size by Region (2020-2025)
8.4 Asia-Pacific Bioprocessing Development Software 麻豆原创 Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Bioprocessing Development Software 麻豆原创 Size (2020-2031)
9.2 Latin America Bioprocessing Development Software 麻豆原创 Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Bioprocessing Development Software 麻豆原创 Size by Country (2020-2025)
9.4 Latin America Bioprocessing Development Software 麻豆原创 Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Bioprocessing Development Software 麻豆原创 Size (2020-2031)
10.2 Middle East & Africa Bioprocessing Development Software 麻豆原创 Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Bioprocessing Development Software 麻豆原创 Size by Country (2020-2025)
10.4 Middle East & Africa Bioprocessing Development Software 麻豆原创 Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Merck
11.1.1 Merck Company Details
11.1.2 Merck Business Overview
11.1.3 Merck Bioprocessing Development Software Introduction
11.1.4 Merck Revenue in Bioprocessing Development Software Business (2020-2025)
11.1.5 Merck Recent Development
11.2 Genedata
11.2.1 Genedata Company Details
11.2.2 Genedata Business Overview
11.2.3 Genedata Bioprocessing Development Software Introduction
11.2.4 Genedata Revenue in Bioprocessing Development Software Business (2020-2025)
11.2.5 Genedata Recent Development
11.3 Invert
11.3.1 Invert Company Details
11.3.2 Invert Business Overview
11.3.3 Invert Bioprocessing Development Software Introduction
11.3.4 Invert Revenue in Bioprocessing Development Software Business (2020-2025)
11.3.5 Invert Recent Development
11.4 Eppendorf
11.4.1 Eppendorf Company Details
11.4.2 Eppendorf Business Overview
11.4.3 Eppendorf Bioprocessing Development Software Introduction
11.4.4 Eppendorf Revenue in Bioprocessing Development Software Business (2020-2025)
11.4.5 Eppendorf Recent Development
11.5 Koerber-Pharma
11.5.1 Koerber-Pharma Company Details
11.5.2 Koerber-Pharma Business Overview
11.5.3 Koerber-Pharma Bioprocessing Development Software Introduction
11.5.4 Koerber-Pharma Revenue in Bioprocessing Development Software Business (2020-2025)
11.5.5 Koerber-Pharma Recent Development
11.6 Vimachem
11.6.1 Vimachem Company Details
11.6.2 Vimachem Business Overview
11.6.3 Vimachem Bioprocessing Development Software Introduction
11.6.4 Vimachem Revenue in Bioprocessing Development Software Business (2020-2025)
11.6.5 Vimachem Recent Development
11.7 Alkemy Innovation
11.7.1 Alkemy Innovation Company Details
11.7.2 Alkemy Innovation Business Overview
11.7.3 Alkemy Innovation Bioprocessing Development Software Introduction
11.7.4 Alkemy Innovation Revenue in Bioprocessing Development Software Business (2020-2025)
11.7.5 Alkemy Innovation Recent Development
11.8 Cytiva
11.8.1 Cytiva Company Details
11.8.2 Cytiva Business Overview
11.8.3 Cytiva Bioprocessing Development Software Introduction
11.8.4 Cytiva Revenue in Bioprocessing Development Software Business (2020-2025)
11.8.5 Cytiva Recent Development
11.9 IDBS
11.9.1 IDBS Company Details
11.9.2 IDBS Business Overview
11.9.3 IDBS Bioprocessing Development Software Introduction
11.9.4 IDBS Revenue in Bioprocessing Development Software Business (2020-2025)
11.9.5 IDBS Recent Development
11.10 Infors
11.10.1 Infors Company Details
11.10.2 Infors Business Overview
11.10.3 Infors Bioprocessing Development Software Introduction
11.10.4 Infors Revenue in Bioprocessing Development Software Business (2020-2025)
11.10.5 Infors Recent Development
11.11 Sapio
11.11.1 Sapio Company Details
11.11.2 Sapio Business Overview
11.11.3 Sapio Bioprocessing Development Software Introduction
11.11.4 Sapio Revenue in Bioprocessing Development Software Business (2020-2025)
11.11.5 Sapio Recent Development
11.12 Sartorius
11.12.1 Sartorius Company Details
11.12.2 Sartorius Business Overview
11.12.3 Sartorius Bioprocessing Development Software Introduction
11.12.4 Sartorius Revenue in Bioprocessing Development Software Business (2020-2025)
11.12.5 Sartorius Recent Development
11.13 Securecell
11.13.1 Securecell Company Details
11.13.2 Securecell Business Overview
11.13.3 Securecell Bioprocessing Development Software Introduction
11.13.4 Securecell Revenue in Bioprocessing Development Software Business (2020-2025)
11.13.5 Securecell Recent Development
11.14 Synthace
11.14.1 Synthace Company Details
11.14.2 Synthace Business Overview
11.14.3 Synthace Bioprocessing Development Software Introduction
11.14.4 Synthace Revenue in Bioprocessing Development Software Business (2020-2025)
11.14.5 Synthace Recent Development
11.15 Thermo Fisher Scientific
11.15.1 Thermo Fisher Scientific Company Details
11.15.2 Thermo Fisher Scientific Business Overview
11.15.3 Thermo Fisher Scientific Bioprocessing Development Software Introduction
11.15.4 Thermo Fisher Scientific Revenue in Bioprocessing Development Software Business (2020-2025)
11.15.5 Thermo Fisher Scientific Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 麻豆原创 Size Estimation
13.1.1.3 麻豆原创 Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer

Companies Mentioned:

Merck
Genedata
Invert
Eppendorf
Koerber-Pharma
Vimachem
Alkemy Innovation
Cytiva
IDBS
Infors
Sapio
Sartorius
Securecell
Synthace
Thermo Fisher Scientific

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.